Hatzimouratidis, K
Buvat, J
Büttner, H
Vendeira, P A S
Moncada, I
Boehmer, M
Henneges, C
Boess, F G
Article History
Received: 12 June 2013
Revised: 4 March 2014
Accepted: 27 March 2014
First Online: 1 May 2014
Competing interests
: KH has served as speaker for Eli Lilly. JB has received honorary as scientific advisor for Eli Lilly and has been clinical trial investigator for trials sponsored by Eli Lilly, Bayer-Schering, Boehringer Ingelheim and Janssen-Cilag. IM has served as scientific advisor and speaker for Janssen-Cilag, Eli Lilly and Co., Bayer-Schering; and has received research grants from Pfizer. IM, KH, MB and PASV have been clinical trial investigator for trials sponsored by Eli Lilly. HB, CH and FGB are employees of Eli Lilly and Company; HB and FGB also own Lilly stock.